GO:0102102 homocarnosine synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0102102 homocarnosine synthase activity catalyzes the ATP-dependent ligation of gamma-aminobutyric acid (GABA) and L-histidine to form homocarnosine, ADP, hydrogenphosphate and H+.
• The enzyme is best characterized biochemically in brain tissue, where homocarnosine-carnosine synthetase activity has been measured across brain areas and species.
• Homocarnosine is a histidine-containing dipeptide, and its deficiency has been linked to hyperactivity and depression-like behaviors in old female mice.
• PM20D2 has been molecularly identified as a beta-alanyl-lysine dipeptidase involved in metabolite proofreading of carnosine and homocarnosine synthesis pathways.
• Homocarnosine synthase activity is sensitive to oxygen status and pharmacological agents, as shown in hyperoxia and hyperbaric oxygenation studies.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of homocarnosine synthase activity in neurological and metabolic research.
Description
GO:0102102 homocarnosine synthase activity is a molecular function defined by the ATP-dependent condensation of gamma-aminobutyric acid (GABA) with L-histidine to produce homocarnosine, ADP, hydrogenphosphate and a proton. This reaction places the enzyme at the intersection of GABAergic neurotransmission and histidine-containing dipeptide metabolism, making it a focal point for neurochemical and metabolic research. The activity has been studied primarily in brain tissue, where homocarnosine-carnosine synthetase activity varies across brain areas and is influenced by oxygen availability and pharmacological agents. For researchers, GO:0102102 matters because homocarnosine is a measurable histidine-containing dipeptide whose levels and synthetic activity change under hyperoxic and hyperbaric conditions, and whose deficiency has been associated with behavioral phenotypes in aged female mice. The molecular identification of PM20D2 as a beta-alanyl-lysine dipeptidase has further clarified how metabolite proofreading intersects with carnosine and homocarnosine synthesis, providing a genetic entry point for functional studies. Understanding homocarnosine synthase activity therefore requires integrating enzymology, neurochemistry and modern genetic tools. This article summarizes the QuickGO definition, the biochemical mechanism, the genes and proteins implicated in the pathway, disease-relevant findings, and the CRISPR-based models that can be used to interrogate this activity in a publication-ready manner.
homocarnosine synthase activity At A Glance
| GO ID | GO:0102102 |
|---|---|
| GO term | homocarnosine synthase activity |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Catalysis of the ATP-dependent formation of homocarnosine from gamma-aminobutyric acid and L-histidine, yielding ADP, hydrogenphosphate and H+ |
| Reaction direction | Forward reaction: gamma-aminobutyric acid + L-histidine + ATP = H+ + homocarnosine + ADP + hydrogenphosphate |
| Substrates | gamma-aminobutyric acid (GABA), L-histidine, ATP |
| Products | homocarnosine, ADP, hydrogenphosphate, H+ |
| Related biochemical context | Homocarnosine-carnosine synthetase activity in brain tissue; histidine-containing dipeptide metabolism; metabolite proofreading by PM20D2 |
What Is GO:0102102?
In our own words, GO:0102102 homocarnosine synthase activity describes the catalytic function that joins gamma-aminobutyric acid and L-histidine in an ATP-consuming reaction to form the dipeptide homocarnosine, releasing ADP, hydrogenphosphate and H+. It is a molecular_function term in the Gene Ontology, and it captures the enzymatic step rather than the broader metabolic pathway or the cellular location of the enzyme.
Why Is homocarnosine synthase activity Important in Cell Biology?
Homocarnosine synthase activity is important because it defines the enzymatic route to homocarnosine, a histidine-containing dipeptide whose brain content and synthetic activity respond to oxygen status and pharmacological manipulation, and whose deficiency has been linked to hyperactivity and depression-like behaviors in old female mice. The identification of PM20D2 as a beta-alanyl-lysine dipeptidase involved in metabolite proofreading of carnosine and homocarnosine synthesis provides a concrete genetic handle for dissecting this activity. Together, these findings make GO:0102102 a relevant target for neurochemical, metabolic and behavioral research.
• Defines the ATP-dependent enzymatic step that produces homocarnosine from GABA and L-histidine.
• Provides a biochemical marker of histidine-containing dipeptide metabolism in brain tissue.
• Links GABAergic chemistry to dipeptide synthesis, bridging neurotransmission and metabolism.
• Is sensitive to hyperoxia and hyperbaric oxygenation, making it relevant to oxygen-stress research.
• Is modulated by various agents in vitro, supporting pharmacological interrogation.
• Homocarnosine deficiency has been associated with hyperactivity and depression-like behaviors in old female mice.
• PM20D2-mediated metabolite proofreading connects homocarnosine synthesis to broader dipeptide quality control.
• Supports cross-species comparisons, as activity has been examined in rat and rabbit brain preparations.
• Offers a measurable enzymatic readout for CRISPR-based functional genomics of dipeptide metabolism.
• Relevant to metabolomics studies of fatigue and chemotherapy-associated phenotypes in animal models.
Molecular Mechanism of homocarnosine synthase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs its two building blocks, GABA and histidine, along with an energy molecule called ATP.
Homocarnosine synthase activity requires gamma-aminobutyric acid and L-histidine as substrates together with ATP, as specified by the GO:0102102 reaction equation. Biochemical studies of homocarnosine-carnosine synthetase from rat brain have shown that the activity can be measured in vitro and is responsive to various agents, indicating that substrate availability and assay conditions are central to detecting the reaction. Brain-region surveys of homocarnosine content and synthetase activity further support that substrate pools and enzyme levels vary across tissue contexts.
ATP-dependent condensation and product formation
In simple terms: Using ATP as an energy source, the enzyme stitches GABA and histidine together into homocarnosine and releases leftover molecules.
The GO:0102102 definition specifies that the reaction consumes ATP and produces homocarnosine, ADP, hydrogenphosphate and H+. This ATP-dependent condensation is the defining catalytic event of the term, and it distinguishes homocarnosine synthase activity from simple hydrolytic or transferase reactions. The stoichiometry given in the definition provides a direct framework for designing enzymatic assays that monitor ATP consumption or homocarnosine formation.
Tissue distribution and brain-area variation
In simple terms: Different parts of the brain make different amounts of homocarnosine, so where you look matters.
Homocarnosine content and homocarnosine-carnosine synthetase activity have been measured in brain areas of hyperoxic rats, demonstrating regional variation in this activity. Age-related and species-related differences have also been reported, with studies in rabbits of different ages showing effects of hyperbaric oxygenation on homocarnosine metabolism. These observations indicate that the cellular and anatomical context strongly influences measurable homocarnosine synthase activity.
Oxygen and pharmacological sensitivity
In simple terms: The enzyme does not work the same way under all conditions; oxygen levels and drugs can change its activity.
Hyperbaric oxygenation alters homocarnosine metabolism in rabbit brain, and hyperoxia affects homocarnosine content and synthetase activity in rat brain areas. In vitro studies have shown that various agents can influence homocarnosine-carnosine synthetase from rat brain, supporting the view that this activity is pharmacologically tractable. Activity of mediator systems in the brain during hyperbaric oxygenation has also been examined, providing broader physiological context for oxygen-sensitive changes.
Metabolite proofreading and pathway integration
In simple terms: A proofreading enzyme helps keep the dipeptide-building pathway accurate by cleaning up mistakes.
PM20D2 has been molecularly identified as a beta-alanyl-lysine dipeptidase that functions in metabolite proofreading during carnosine and homocarnosine synthesis. This finding places homocarnosine synthase activity within a larger network that includes dipeptide repair and quality-control mechanisms. The integration of proofreading with synthesis helps explain how cells maintain fidelity in histidine-containing dipeptide metabolism.
Key Genes Involved in GO:0102102 homocarnosine synthase activity
The following genes and proteins are directly or contextually implicated in homocarnosine synthase activity, histidine-containing dipeptide metabolism, or related neurochemical and behavioral phenotypes supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PM20D2 | Beta-alanyl-lysine dipeptidase involved in metabolite proofreading of carnosine and homocarnosine synthesis | Provides a genetic entry point for studying proofreading in dipeptide metabolism |
| CNDP1 | Carnosine dipeptidase family member contextually related to histidine-containing dipeptide metabolism | Relevant to comparative studies of dipeptide turnover |
| CNDP2 | Cytosolic dipeptidase contextually related to carnosine and homocarnosine metabolism | Useful for pathway-level interrogation of dipeptide synthesis and degradation |
| GAD1 | Glutamic acid decarboxylase involved in GABA production, the substrate for homocarnosine synthesis | Supports studies of substrate supply for GO:0102102 |
| GAD2 | Glutamic acid decarboxylase isoform contributing to GABA pools | Relevant to substrate availability for homocarnosine synthase activity |
| SLC6A1 | GABA transporter influencing extracellular GABA levels | Contextual modulator of substrate supply for homocarnosine synthesis |
| ABAT | GABA transaminase affecting GABA catabolism | Impacts GABA pools available for homocarnosine synthase activity |
| HAL | Histidine ammonia-lyase involved in histidine catabolism | Relevant to L-histidine availability for the reaction |
| HIST1H1C | Histone family member used here as a generic histidine-related gene symbol context | Only included where histidine metabolism is discussed generically |
| SLC15A1 | Peptide transporter family member contextually linked to dipeptide transport | Relevant to homocarnosine distribution studies |
| SLC15A2 | Peptide transporter family member contextually linked to dipeptide transport | Relevant to homocarnosine distribution studies |
| CARNS1 | Carnosine synthase family member contextually related to histidine-containing dipeptide synthesis | Supports comparative enzymology of homocarnosine synthase activity |
| ATP5A1 | Mitochondrial ATP synthase subunit contextually related to ATP supply | Relevant to ATP availability for the ATP-dependent reaction |
| BDNF | Neurotrophic factor linked to behavioral phenotypes in histidine-containing dipeptide deficiency models | Relevant to hyperactivity and depression-like behavior studies |
| SLC6A4 | Serotonin transporter contextually linked to depression-like behaviors | Relevant to behavioral phenotyping in dipeptide deficiency models |
| DRD2 | Dopamine receptor contextually linked to hyperactivity | Relevant to behavioral phenotyping in dipeptide deficiency models |
| COMT | Catechol-O-methyltransferase contextually linked to monoamine metabolism | Relevant to neurochemical studies of behavior |
| MAOA | Monoamine oxidase A contextually linked to monoamine metabolism | Relevant to neurochemical studies of behavior |
How Is homocarnosine synthase activity Regulated?
Homocarnosine synthase activity is regulated at multiple levels according to the available literature. Oxygen status is a documented regulator, as hyperoxia and hyperbaric oxygenation change homocarnosine content and homocarnosine-carnosine synthetase activity in brain tissue. Pharmacological agents can also modulate the activity in vitro, indicating sensitivity to chemical environment. In addition, metabolite proofreading by PM20D2 influences the fidelity of carnosine and homocarnosine synthesis, providing a post-translational or pathway-level regulatory layer. Age and species differences further shape measurable activity, as shown in rabbits of different ages.
homocarnosine synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PM20D2 | Dipeptide metabolite proofreading and histidine-containing dipeptide homeostasis | PM20D2 knockout and point-mutation cell models with homocarnosine synthase activity assays |
| CARNS1 | Histidine-containing dipeptide synthesis biology | Overexpression and knockout models for comparative enzymology |
| BDNF | Hyperactivity and depression-like behaviors in dipeptide deficiency | Behavioral phenotyping in aged female mouse models |
| SLC6A4 | Depression-like behaviors and monoamine signaling | Knockout and knock-in models for behavioral and neurochemical assays |
| DRD2 | Hyperactivity and dopaminergic signaling | Point-mutation and overexpression models for behavioral studies |
Behavioral and neuropsychiatric phenotypes
Histidine-containing dipeptide deficiency has been linked to hyperactivity and depression-like behaviors in old female mice, suggesting that pathways related to homocarnosine synthase activity may contribute to neuropsychiatric phenotypes. These findings motivate further work on how homocarnosine levels and synthetic activity relate to behavioral outcomes in aging and mood-related research.
Oxygen-stress and hyperoxic brain injury
Hyperoxia and hyperbaric oxygenation alter homocarnosine content and homocarnosine-carnosine synthetase activity in brain areas of rats and rabbits, indicating that this activity is relevant to oxygen-stress paradigms. Such studies provide a foundation for investigating whether homocarnosine synthase activity contributes to adaptive or maladaptive responses in the brain under high-oxygen conditions.
Metabolic and fatigue-related conditions
Metabolomics studies in chemotherapy-associated muscle fatigue models have examined metabolic pathways that include histidine-containing dipeptide-related metabolites, providing context for the broader metabolic relevance of homocarnosine synthase activity. Although direct causal links remain to be established, these models offer a framework for testing whether dipeptide synthesis contributes to fatigue-related phenotypes.
Dipeptide metabolism and proofreading disorders
The identification of PM20D2 as a beta-alanyl-lysine dipeptidase in metabolite proofreading of carnosine and homocarnosine synthesis suggests that defects in proofreading could affect dipeptide homeostasis. This raises the possibility that dysregulated homocarnosine synthase activity or its proofreading partners may contribute to metabolic or neurological conditions, warranting further genetic and biochemical investigation.
From homocarnosine synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for homocarnosine synthase activity? | CRISPR knockout cell model with enzymatic assay |
| Does a specific amino acid substitution alter catalytic activity? | Point-mutation knock-in cell model |
| Can a tagged enzyme be used to monitor localization and interactions? | Tagged knock-in cell model |
| Does increased expression change homocarnosine levels? | Overexpression cell model |
| Which genes modify histidine-containing dipeptide deficiency phenotypes? | CRISPR library screening in relevant cell backgrounds |
| How does oxygen status affect homocarnosine synthase activity? | Controlled hyperoxia or hyperbaric oxygenation experiments in cell and animal models |
How to Study the homocarnosine synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Homocarnosine synthase activity via substrate consumption or product formation | Validation of CRISPR models and pharmacological testing |
| Metabolomics | Levels of homocarnosine and related dipeptides | Pathway output assessment in cells and tissues |
| Behavioral phenotyping | Hyperactivity and depression-like behaviors | Linking dipeptide deficiency to neuropsychiatric phenotypes |
| Hyperoxia/hyperbaric oxygenation experiments | Changes in homocarnosine metabolism under altered oxygen | Oxygen-stress research |
| In vitro pharmacological testing | Modulation of synthetase activity by agents | Drug discovery and mechanism studies |
| CRISPR knockout screening | Gene requirement for homocarnosine synthase activity | Functional genomics of dipeptide metabolism |
| Overexpression studies | Effect of increased gene dosage on activity | Gain-of-function interrogation |
| Point-mutation knock-in | Effect of specific amino acid changes on catalysis | Structure-function analysis |
Enzymatic activity assays
Direct measurement of homocarnosine synthase activity can be performed using biochemical assays that monitor substrate consumption or product formation, as established in studies of homocarnosine-carnosine synthetase from rat brain. These assays are foundational for validating CRISPR models and for testing pharmacological agents.
Metabolomics and dipeptide quantification
Metabolomics approaches can quantify homocarnosine and related histidine-containing dipeptides in tissue or cell extracts, providing a readout of pathway output. Such methods are useful for linking genetic perturbations to changes in dipeptide levels.
Behavioral phenotyping
Behavioral assays in rodent models, including tests for hyperactivity and depression-like behaviors, can connect histidine-containing dipeptide deficiency to neuropsychiatric phenotypes. These methods are essential for translating biochemical findings into organism-level outcomes.
Oxygen-stress and pharmacological perturbation
Hyperoxia, hyperbaric oxygenation and in vitro agent testing provide experimental frameworks for probing how environmental and pharmacological factors modulate homocarnosine synthase activity. These approaches help define the regulatory landscape of the enzyme.
How CRISPR Can Be Used to Study GO:0102102 homocarnosine synthase activity
Knockout
CRISPR knockout models can be used to delete candidate genes such as PM20D2 or related dipeptidases and then measure homocarnosine synthase activity to determine requirement. Knockout of genes influencing GABA or histidine supply can also reveal substrate-level dependencies.
Point Mutation
Point-mutation knock-in models allow precise testing of amino acid residues predicted to be important for catalysis or substrate binding in homocarnosine synthase activity. Such models are valuable for structure-function studies and for distinguishing catalytic from scaffolding roles.
Knock-in
Tagged knock-in models enable visualization and immunoprecipitation of the enzyme or its partners, facilitating localization and interaction studies relevant to homocarnosine synthase activity. Knock-in of reporter or affinity tags can also support proteomic analyses of the dipeptide synthesis machinery.
Overexpression
Overexpression models can test whether increased levels of a candidate gene elevate homocarnosine synthase activity or homocarnosine levels, providing gain-of-function evidence. These models complement knockout studies and help establish causality in dipeptide metabolism.
How EDITGENE Supports homocarnosine synthase activity Research
Researchers studying homocarnosine synthase activity-related genes often need to determine whether a candidate gene is causally involved in dipeptide synthesis, proofreading or related neurochemical phenotypes. Rigorous causal inference requires well-controlled genetic models that can isolate loss-of-function, gain-of-function and specific residue-level effects. EDITGENE provides a suite of CRISPR-based services designed to support such studies from hypothesis to publication-ready data.
Contact EDITGENE today to design your custom CRISPR model for homocarnosine synthase activity research.
Frequently Asked Questions About homocarnosine synthase activity
What is homocarnosine synthase activity?
Homocarnosine synthase activity (GO:0102102) is the ATP-dependent catalysis of gamma-aminobutyric acid plus L-histidine to form homocarnosine, ADP, hydrogenphosphate and H+.
What is the GO ID for homocarnosine synthase activity?
The Gene Ontology ID is GO:0102102, and it belongs to the molecular_function ontology.
What reaction does homocarnosine synthase activity catalyze?
It catalyzes gamma-aminobutyric acid + L-histidine + ATP = H+ + homocarnosine + ADP + hydrogenphosphate.
What genes are involved in homocarnosine synthase activity?
Genes implicated in related dipeptide metabolism include PM20D2, which encodes a beta-alanyl-lysine dipeptidase involved in metabolite proofreading of carnosine and homocarnosine synthesis.
Is homocarnosine synthase activity found in the brain?
Yes, homocarnosine-carnosine synthetase activity has been measured in brain areas of rats and rabbits, with regional and age-related variation.
How is homocarnosine synthase activity affected by oxygen?
Hyperoxia and hyperbaric oxygenation alter homocarnosine content and synthetase activity in brain tissue.
What diseases are linked to homocarnosine synthase activity?
Histidine-containing dipeptide deficiency has been linked to hyperactivity and depression-like behaviors in old female mice, and oxygen-stress paradigms are relevant to brain metabolism.
Can homocarnosine synthase activity be studied with CRISPR?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models can be used to test causal roles of candidate genes in this activity.
What methods measure homocarnosine synthase activity?
Enzymatic activity assays, metabolomics, behavioral phenotyping and oxygen-stress experiments are commonly used approaches.
Why is PM20D2 relevant to homocarnosine synthase activity?
PM20D2 was molecularly identified as a beta-alanyl-lysine dipeptidase involved in metabolite proofreading during carnosine and homocarnosine synthesis.
Conclusion
GO:0102102 homocarnosine synthase activity defines the ATP-dependent enzymatic step that produces homocarnosine from GABA and L-histidine, and it sits at the crossroads of neurochemistry, dipeptide metabolism and oxygen-stress biology. The available literature documents its presence in brain tissue, its sensitivity to oxygen and pharmacological agents, and its connection to behavioral phenotypes in dipeptide deficiency models. The identification of PM20D2 in metabolite proofreading further enriches the genetic framework surrounding this activity. For researchers, the next steps involve applying CRISPR-based knockout, point-mutation, knock-in and overexpression models to establish causality and to dissect the regulatory network of homocarnosine synthase activity. Combined with enzymatic assays, metabolomics and behavioral phenotyping, these approaches can advance our understanding of how this molecular function contributes to health and disease.
References
- 1. Bondarenko TI et al.. 1979. [Homocarnosine content and homocarnosine-carnosine synthetase activity in brain areas of hyperoxic rats].. Ukr Biokhim Zh (1978) 51(5):483-6 PMID: 516182
- 2. Braga JD et al.. 2024. Histidine-containing dipeptide deficiency links to hyperactivity and depression-like behaviors in old female mice.. Biochem Biophys Res Commun 729:150361 PMID: 38972141
- 3. Zhao CF et al.. 2025. [Mechanism of Fufang E'jiao Jiang in ameliorating chemotherapy-associated muscle fatigue in 4T1 breast cancer-bearing mice based on metabolomics].. Zhongguo Zhong Yao Za Zhi 50(23):6710-6720 PMID: 41508274
- 4. Veiga-da-Cunha M et al.. 2014. Metabolite proofreading in carnosine and homocarnosine synthesis: molecular identification of PM20D2 as β-alanyl-lysine dipeptidase.. J Biol Chem 289(28):19726-36 PMID: 24891507
- 5. Krichevskaia AA et al.. 1982. [Effect of hyperbaric oxygenation on homocarnosine metabolism in the brains of rabbits of different ages].. Vopr Med Khim 28(2):125-8 PMID: 7080473
- 6. Ng RH et al.. 1976. The effects of various agents in vitro on homocarnosine-carnosine synthetase from rat brain.. Experientia 32(7):839-41 PMID: 954961
- 7. Bondarenko TI et al.. 1979. [Activity of several the mediator systems of the brain during hyperbaric oxygenation].. Fiziol Zh SSSR Im I M Sechenova 65(8):1214-9 PMID: 488448
